The involvement of elevated intracellular polyamines in colorectal tumorigenesis has been known for many years and many reports have documented the ability of the ODC inhibitor DFMO to limit tumor formation and progression in preclinical models, as well as its chemopreventive efficacy in clinical trials13. The gene discussed is ODC1; the disease is neoplasm.